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Frailty is associated with an increased incidence of adverse peri-operative outcomes; its 
accurate identification is complex and quantification of its impact on outcomes consequently 
fraught with difficulty. Sarcopenia, the degenerative loss of core muscle mass, is an indicator 
of frailty and its radiological quantitation has shown promise in providing an objective 
morphometric measure that may facilitate risk stratification. Patients presenting for elective 
abdominal aortic aneurysm surgery routinely undergo pre-operative computed tomography 
(CT) imaging, permitting diagnosis of sarcopenia by measurement of Psoas Area (PA) with 
derivatives such as the L4-Psoas Muscle Index (L4-PMI (mm2/m2), psoas muscle cross-
sectional area at the fourth lumbar vertebra, corrected for height). We studied the impact of 
sarcopenia on, and its independent association with, post-operative outcomes following 
elective abdominal aortic aneurysm surgery. Psoas area and derivative indices were 
calculated retrospectively for 137 patients and its association with survival and other 
outcomes including post-operative complications, length of intensive care and hospital stay 
analysed. This study found an association between reduced post-operative survival and 
abdominal muscle mass, with left PA and patient age as independent predictors of survival 
and length of hospital stay. Our results strengthen the case for inclusion of muscle mass 
indices during pre-operative evaluation and risk-stratification in patients presenting for 

















Elective surgery for abdominal aortic aneurysms (AAA) aims to prevent death or serious 
morbidity from rupture. This is a preventative operation in often asymptomatic patients and 
the decision to proceed with elective AAA repair must balance the risk of rupture with that of 
perioperative complications.    
The widespread use of endovascular techniques, now accounting for the majority of AAA 
repairs carried out, has led to surgery being offered to a broader group of patients, who are 
increasingly elderly and have significant co-morbidities [1]. While outcomes, particularly in 
the short-term, are improving, the risk of perioperative complications remains significant. 
Research into outcomes and pre-operative prognostication has largely focused on 
cardiopulmonary fitness, but much less on the role of frailty. 
Sarcopenia is the degenerative loss of core muscle mass and function. It is a component of a 
multi-factorial process that leads to frailty with advancing age.  Its prevalence is believed to 
be substantial in adults aged over 65 years [2,3] and increases with age, institutionalisation 
and acute illness.  
Sarcopenia is known to exist even in patients who are otherwise healthy and in the obese, as 
it is independent of total body mass [4]. It may therefore go undetected in patients not 
appearing frail on visual assessment. Objective quantification of core muscle loss, as assessed 
by psoas muscle area, is a simple and robust [5] means of identifying frailty. It can be carried 
out with little additional impact on resources using CT images that form part of the routine 
pre-operative work-up for patients undergoing AAA surgery. 
It is recognised that sarcopenia is associated with higher levels of disability and unfavourable 
outcomes in patients with chronic conditions such as heart failure or neurological disease 
[6,7]. Furthermore, post-operative outcome data from numerous studies including colorectal 
and hepatobiliary cancer surgery indicates that sarcopenia may be an independent predictor of 
poorer surgical outcomes [8-11]. This includes significantly higher rates of infective 
complications, length of hospital stay and death.  
Lee et al’s study of outcomes after open AAA repair in 262 patients concluded that reduced 
core muscle size correlates strongly with increased mortality [12]. However, the evidence 
base for the role of sarcopenia on morbidity in the vascular surgery population, particularly 
for patients undergoing endovascular aneurysm repair (EVAR) remains small. 
Currently, most risk stratification models for AAA repair have limited predictive ability [13] 
and do not account for frailty. Inclusion of an objective, morphometric measure of sarcopenia 
as a marker of frailty may also allow targeted modification of perioperative risk, or 
‘prehabilitation’, using nutritional, exercise and pharmacological interventions which have 
shown some promise in reversing the effects of sarcopenia [14,15]. 
The aim of this study was to assess the impact of sarcopenia on post-operative outcomes in 
patients undergoing elective AAA surgery and its potential as an independent factor to aid 
risk-prediction in this population.  
  
Methods 
We did not seek ethical approval for this retrospective analysis of data that were routinely 
collected for patients scheduled for abdominal aortic aneurysm repair at the Royal Free 
Hospital, London, UK, between February 2012 and December 2014.  
We analysed the associations of independent variables with postoperative outcomes. 
The independent variables were muscle areas on CT and patient sex, age at operation, height, 
weight and body mass index, renal function (eGFR) and history of myocardial infarction, 
angina, stroke, transient cerebral ischaemia and hypercholesterolaemia. The CT images were 
recorded within 12 pre-operative months, or within 3 postoperative months if pre-operative 
scans were unavailable or of insufficient quality. The primary postoperative outcome was 
survival; secondary postoperative outcomes were: complications; length of intensive care unit 
(ICU) and hospital stays; and discharge destination (home or further care). We used the 
Clavien-Dindo Classification to grade postoperative complications. 
Two radiologists unaware of patient outcomes measured two muscle areas: total 
abdominal muscle area (TAMA); and total psoas area (TPA). We used software that semi-
automatically derived muscle area at the level of the fourth lumbar vertebra: the radiologists 
then traced the area of each psoas by hand, which when summed gave a combined psoas area 
(mm2) [10,12,16]. We standardised muscle areas to patient: height (mm2.m-2); weight 
(mm2.kg-1); and body size (mm.kg-0.83) [ref]. In addition, superficial, visceral and total 
abdominal fat areas (SFA, VFA and TFA, respectively) were also measured [17].  
We included all patients recorded in our database at the time of analysis. A sample 
size calculation was therefore not carried out.  We used the chi-squared test to compare 
categorical variables and Student’s t-test or Mann-Whitney U test to compare continuous 
variables, as appropriate.  Univariable Cox regression analyses were performed individually 
to assess the association of independent variables with survival and secondary outcomes 
using the Efron method for tied failures. Variables with p values <0.05 were used to generate 
multivariable survival and other outcome models. The Akaike Information Criterion was used 
to select the model with the highest information. We used SPSS Version 24.0 (IBM, Chicago, 





Demographic information for the study cohort are shown in Table 1.  The primary measure of 
sarcopenia in this study, L4-PMI, had a mean value of 814.5.4 mm2/m2 (SD 156.2) in male 
patients and 639.9mm2/m2 (SD 199.0) in female patients.  
In 17 patients (12.4%), post-operative CT scans were used for analysis due to suitable pre-
operative images being unavailable.  
The primary outcome measure, longest median post-operative survival, was 3.8 years (IQR 
3.2 – 4.4 [range 3 days – 5.1 years]). One-year mortality was 3.7% (n=5) and twenty-three 
patients (16.7%) died during the 5-year follow up period. Univariate Cox regression showed 
patient age (p= 0.010) and left PA (p= 0.049) to be the only covariables independently 
associated with survival (Table 2). This relationship was more marked when left PA was 
adjusted for weight (left PA-W, p= 0.027) and body size (left PA-S, p=0.021). Multivariate 
regression analysis showed no significant reduction in survival associated with a reduced left 
PA-S (p = 0.080) but a significant association with patient age (p = 0.034) (Table 3). We also 
fitted our data to a multivariate regression model as used in a validated AAA survival 
calculator [16], which similarly showed that age (p = 0.029) but not PA-W (p = 0.073) were 
independently associated with survival. This survival calculator predicted accurately (within 
95% CI) the actual survival in our patient cohort (Figure 1).  
Analysis of secondary outcomes revealed an incidence of in-hospital post-operative 
complications of 35.0% (n=48): Eighteen patients (13.1%) suffered from respiratory 
complications; 16 (11.7%) from cardiovascular complications; Nine (6.6%) from renal 
complications and 9 (6.6%) from neurological complications. Of these complications, 27% 
(13/48) were categorised as severe (CDC Grade 3 or higher).  
Fifteen patients (10.9%) required a return to the operating theatre during their stay. Fourteen 
patients (10.2%) could not be discharged home, as they required further care such as 
rehabilitation or transfer to another hospital for additional interventions. 
Median ICU length of stay for the entire cohort was 2 days (IQR 1-3 [Range 0-79]) and 
median hospital length of stay 5 days (IQR 3-9 [Range 1-105]). Multivariate regression 
showed that 2 covariables were independently associated with hospital length of stay: left 
PA-S (PA corrected for body size; Hazard ratio (HR) 1.021, (95% Confidence interval (CI) 




This study examines the role of sarcopenia as an independent predictor of post-operative 
outcomes in patients undergoing abdominal aortic aneurysm repair predominantly performed 
using an endovascular approach.  
Age and left PA-S (psoas area corrected for body size) emerged as the 2 covariables 
independently predictive of survival. An increase in left PA-S is associated with a higher 
chance of survival. Our findings are corroborated by other studies that found strong 
correlations between reduced core muscle mass and increased mortality following open AAA 
repair [12].  Our results further strengthen the case for consideration of sarcopenia as a 
predictor for perioperative morbidity following elective AAA repair, which should form part 
of pre-operative risk assessment. Total abdominal muscle area, TAMA, and measures of 
abdominal fat area (SFA, VFA and TFA) did not have any association with post-operative 
outcomes in this study.  
Our results also suggest that sarcopenia is independently associated with a longer length of 
in-hospital stay following AAA surgery. This is an important finding given the conflicting 
results regarding length of stay after surgery that are reported in the literature [18-20]. Our 
results are concordant with studies of patients with long-term co-morbid conditions such as 
colorectal carcinoma or chronic cardiovascular disease. Contradictory results from other 
studies may be due to more heterogenous study populations or varying definitions of 
sarcopenia.  
The median BMI in this study fell within the overweight range, reinforcing the message that 
sarcopenia is not restricted to underweight individuals. The term “sarcopenic obesity” was 
coined to describe this increasingly recognised concept [21]. Our data adds to the body of 
evidence indicating that even overweight and obese individuals may have a degree of muscle 
wasting that puts them at risk of worse outcomes after surgery [8,22,23]. A decline in muscle 
mass in patients with a raised BMI may be more difficult to detect clinically, and evaluation 
of sarcopenia on CT imaging may prove particularly valuable in this patient group.   
The value of accurate pre-operative risk prediction extends beyond improved surgical 
planning and resource allocation. A key element of the informed consent process, risk 
calculators have the potential to guide appropriate counselling, promote autonomous 
decision-making and facilitate the provision of individualised care. The role of frailty on peri-
operative outcomes currently plays a limited role in most validated risk calculators used in 
vascular surgical patients, including NSQIP and GUPTA. This may be, at least in part, 
attributable to difficulties with objective identification and quantification of frailty [24].  The 
use of cardiopulmonary exercise testing (CPET) has shown promise in quantifying functional 
capacity and predicting post-operative cardiac and pulmonary complications [25] after AAA 
repair. CPET results, however, are subject to a complex interaction of multiple factors and it 
is possible that assessment of L4-PMI and PA-S has independent incremental value. 
An advantage of L4-PMI and PA-S measurement, therefore, is its utility as an independent, 
objective morphometric marker of frailty that requires no additional imaging in this 
population. Furthermore, this extended use of CT measurements, in addition to their primary 
purpose for assessment of aneurysmal anatomy, increases the yield of these radiological 
investigations. This study suggests that even a simple measurement of unilateral psoas 
muscle area could have utility in risk estimation. Inclusion of PA-S in risk calculators, 
perhaps in combination with functional assessments or CPET variables, could lend additional 
power to prediction models and should be the subject of future research.  
Moreover, the use of sarcopenic indices in vascular surgical patients could have more 
extensive application than risk stratification alone. Identification of patients who may benefit 
from pre-operative interventions to improve outcomes, termed ‘prehabilitation’, may reduce 
morbidity and mortality. Studies investigating the impact of pre-operative nutritional 
programmes have demonstrated a significant reduction in post-operative complications, 
length of hospital stay and mortality in sarcopenic patients that was not replicated in study 
participants with normal or high skeletal muscle mass [26,27]. This suggests that 
identification of sarcopenic patients may facilitate targeting of interventions and scarce 
resources at those most likely to benefit and warrants further exploration. 
Limitations of this study include its single centre, retrospective design and modest sample 
size. The study design may lead to selection bias as only cases with complete medical records 
and appropriate CT imaging within an acceptable time of the operation were included.  This 
resulted in the exclusion of 219 patients from the initial cohort of 356.  While the 
retrospective nature of the study may carry some advantages such as reducing the risk of 
confounding by indication, future prospective studies using a larger, multicentre trial design 
would be valuable in assessing the utility of sarcopenia as independent risk predictor.  
There is currently no consensus in the literature regarding a quantitative definition of 
sarcopenia. While some studies use a predefined cut-off point, other authors utilise a cohort-
specific, lowest gender-matched third of patients based on their TPA [28]. We feel the use of 
an unadjusted cut-off value may be inappropriate for this cohort of patients and have 
accordingly utilised the latter approach. Our study assessed muscle mass as measured from 
CT scans and consequently included no measure of muscle function in our analysis, which 
may bring an additional dimension to the assessment [11]. 
Future research into sarcopenia should look to larger, multi-centre prospective studies to 
confirm the findings of this study and assess if sarcopenia can also predict post-operative 
complications. Measures of sarcopenia could be strengthened by assessing muscle function in 
addition to muscle mass, or even looking at the wider concept of frailty. Additionally, the role 
of CPET as part of risk stratification alongside sarcopenia warrants further exploration. 
Meanwhile, efforts must also be made to study which pre-operative interventions hold the 
greatest potential for modifying the increased risk posed by sarcopenia by increasing pre-
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Table 1 Baseline characteristics for 137 patients before scheduled abdominal aortic aneurysm 
repair. Values are mean (SD), median (IQR [range]) or number (proportion). 
 Total (n = 137) 
Sex; male 100 (73%) 
Age; y 73.9 (8.5) 
Height; m 1.68 (1.63-1.74 [1.40-1.90]) 
Weight; kg 77.2 (68.0-91.3 [43.5-145.0]) 
BMI; kg.m-2 27.7 (24.9-31.7 [17.0-48.0]) 
Albumin; g.l-1 42.2 (4.1) 
eGFR; ml.min-1.1.73m-2 66.5 (22.3) 
L4 PMI; mm2.m-2 766.3 (185.6) 
Comorbidity  
 Hypercholesterolaemia 102 (78%) 
 Stroke or TIA 13 (10%) 
 Chronic renal impairment 104 (80%) 
 Myocardial infarction 25 (18%) 
 Angina 35 (26%) 
 Chronic heart failure 3 (2%) 
 Peripheral arterial disease 9 (7%) 
Type of repair  
 Endovascular, not complex 67 (49%) 
 Endovascular, complex 54 (39%) 
 Endovascular, thoraco-abdominal 11 (8%) 
 Open 5 (4%) 
BMI, body mass index; eGFR, estimated glomerular filtration rate (MDRD method); L4 PMI, 
combined cross-sectional areas of left and right psoas muscles at L4 per metre height; TIA, 














Table 2: Univariate regression for pre-operative variables associated with survival in patients undergoing 
AAA repair. Variable associated with survival are highlighted in bold. Hazard ratio > 1 indicates increased 












Age; years 137 1.077 (1.018-1.140) 0.031 2.58 0.01 
Male sex 137 0.813 (0.335-1.978) 0.369 -0.46 0.649 
Weight; kg 137 0.997 (0.973-1.021) 0.012 -0.27 0.787 
Height; m 137 0.051 (0.0004-5.961) 0.123 -1.23 0.22 
BMI; kg.m-2 137 1.010 (0.936-1.090) 0.039 0.25 0.801 
Haemoglobin concentration; g.L-1 131 0.987 (0.967-1.007) 0.01 -1.26 0.207 
Albumin; g.L-1 108 0.943 (0.864-1.029) 0.042 -1.32 0.186 
Creatinine; µmol.kg-1 132 0.997 (0.988-1.007) 0.005 -0.54 0.591 
eGFR; ml.min-1.1.73m -2 137 0.995 (0.979-1.010) 0.008 -0.68 0.496 
L3TAMA: 137 0.943 (0.864-1.029) 0.042 -1.32 0.186 
    L3TAMA; mm2  1.000 (0.988-1.012) 0.006 0.03 0.979 
    L3TAMA index; mm2.m-2  1.010 (0.975-1.046) 0.018 0.57 0.572 
L4: 134     
    SFA; mm2  1.001 (0.998-1.005) 0.002 0.66 0.509 
    VFA; mm2  0.998 (0.994-1.003) 0.002 -0.72 0.469 
    TFA; mm2  1.000 (0.998-1.002) 0.001 0.01 0.992 
    TFA:TAMA ratio   1.019 (0.639-1.626) 0.243 0.08 0.937 
TPA: 134     
    Right + Left TPA; mm2  0.999 (0.999-1.000) 0.0004 -1.65 0.099 
    PMI; mm2.m-2  0.998 (0.996-1.000) 0.0013 -1.61 0.107 
    RightTPA; mm2  0.999 (0.998-1.000) 0.001 -1.25 0.211 
    LeftTPA; mm2  0.999 (0.997-1.000) 0.001 -1.97 0.049 
    LeftTPA corr for weight;  
mm2.kg-1 
 0.854 (0.742-0.983) 0.061 -2.2 0.027 
    LeftTPA corr for body size; 
mm.kg-0.83 
 0.924 (0.864-0.988) 0.032 -2.31 0.021 
CI, Confidence Interval; BMI, Body Mass Index; eGFR, estimated Glomerular Filtration Rate; L3TAMA, 
Total Abdominal Muscle Area at the 3rd lumbar vertebral level; SFA, Superficial Fat Area; VFA, Visceral 
Fat Area; TFA, Total Fat Area; TPA, Total Psoas Area; PMI, Psoas Muscle Index  
Table 3: Multivariate Cox regression for pre-operative variables associated with survival 
in patients undergoing AAA repair. Hazard ratio > 1 indicates increased risk of dying 
 




z p value 
Age; years 1.063 (1.005-1.125) 0.031 2.13 0.034 
Left TPA / Power(kg,-0.83) 0.941 (0.879-1.007) 0.033 -1.75 0.080 
OR, Odds Ratio; CI, Confidence Interval; CVA, Cerebrovascular Accident; eGFR, 























Table 4: Multivariate Cox regression for pre-operative variables associated with Length 
of Hospital of Stay. Hazard ratio > 1 indicates earlier discharge home.  




z p value 
Age; years 1.021 (1.000-1.042) 0.011 1.99 0.047 
Left TPA / Power(kg,-0.83) 1.053 (1.027-1.080) 0.014 3.99 <0.0001 
OR, Odds ratio; CI, confidence interval; TPA, Total psoas area 
 
 
Figure 1 Comparison of Kaplan–Meier curves for actual (up to 5 year) survival ( — ) with 
95% Confidence Intervals ( — ) against predicted survival ( — ), derived from a survival 
calculator [16]. 
[To be supplied as separate document] 
 
